MNKD:NASDAQ
MannKind Corp
$3.79
arrow_downward
-3.81%(-0.15) 1D
$3.86
arrow_upward
+1.80% (+0.068)bedtimeAfter hours
Closed: Sep 10, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MNKD...
Open
$3.90
High
$3.90
Low
$3.76
Mkt. cap
1.22B
Avg. vol.
3.97M
Volume
0.00
52-wk high
$6.51
52-wk low
$2.23
EPS
-$0.14
Beta
1.10
Shares outstanding
321.54M
No. of employees
592
Open
$3.90
High
$3.90
Low
$3.76
Mkt. cap
1.22B
Avg. vol.
3.97M
Volume
0.00
52-wk high
$6.51
52-wk low
$2.23
EPS
-$0.14
Beta
1.10
Shares outstanding
321.54M
No. of employees
592
News stories
From web sources and news partners
Stock Titan
·
11 hours ago
MannKind (NASDAQ: MNKD) director lines up more stock sales under trading plan
Hartford Business Journal
·
18 hours ago
CT drugmaker partners on development of inhaled weight-loss treatment
Profile
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann. Wikipedia
About MannKind Corp
CEOMichael Castagna
Employees592
FoundedFeb 1991
HeadquartersDanbury, Connecticut, United States
SectorBiotechnology
Websitemannkindcorp.com